- Home
- XENE vs PBF Comparison
XENE vs PBF Comparison
Compare XENE & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- PBF
- Stock Information
- Founded
- XENE 1996
- PBF 2008
- Country
- XENE Canada
- PBF United States
- Employees
- XENE N/A
- PBF N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- PBF Integrated oil Companies
- Sector
- XENE Health Care
- PBF Energy
- Exchange
- XENE Nasdaq
- PBF Nasdaq
- Market Cap
- XENE 3.2B
- PBF 3.5B
- IPO Year
- XENE 2014
- PBF 2012
- Fundamental
- Price
- XENE $43.87
- PBF $34.54
- Analyst Decision
- XENE Strong Buy
- PBF Hold
- Analyst Count
- XENE 11
- PBF 12
- Target Price
- XENE $53.55
- PBF $29.67
- AVG Volume (30 Days)
- XENE 782.5K
- PBF 2.7M
- Earning Date
- XENE 11-03-2025
- PBF 10-30-2025
- Dividend Yield
- XENE N/A
- PBF 3.18%
- EPS Growth
- XENE N/A
- PBF N/A
- EPS
- XENE N/A
- PBF N/A
- Revenue
- XENE $7,500,000.00
- PBF $29,544,100,000.00
- Revenue This Year
- XENE N/A
- PBF N/A
- Revenue Next Year
- XENE $207.88
- PBF $3.78
- P/E Ratio
- XENE N/A
- PBF N/A
- Revenue Growth
- XENE N/A
- PBF N/A
- 52 Week Low
- XENE $26.74
- PBF $13.62
- 52 Week High
- XENE $44.23
- PBF $41.48
- Technical
- Relative Strength Index (RSI)
- XENE 68.37
- PBF 47.79
- Support Level
- XENE $39.09
- PBF $32.86
- Resistance Level
- XENE $42.31
- PBF $39.57
- Average True Range (ATR)
- XENE 1.48
- PBF 2.24
- MACD
- XENE 0.31
- PBF -0.67
- Stochastic Oscillator
- XENE 99.40
- PBF 19.50
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.